NICE IDs

09/07/2020

ID1510: Daratumumab in combination for untreated multiple myeloma when stem cell transplant is suitable

08/07/2020

ID1473: Onasemnogene abeparvovec for treating spinal muscular atrophy type 1

08/07/2020

ID1294: Ozanimod for treating relapsing-remitting multiple sclerosis

08/07/2020

ID1534: Apalutamide for treating prostate cancer

08/07/2020

ID1420: Nintedanib for treating interstitial lung disease caused by systemic sclerosis

15/06/2020

ID901: Non-bisphosphonates for treating osteoporosis

10/06/2020

ID3754: Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure

04/05/2020

ID1583: Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab

28/04/2020

ID945: Abiraterone for treating newly diagnosed high risk metastatic hormone-naive prostate cancer

23/04/2020

ID1188: Erenumab for preventing migraine

23/04/2020

ID861: Metreleptin for treating lipodystrophy

21/04/2020

ID1368: Fremanezumab for preventing migraine

21/04/2020

ID1596: Ropeginterferon alfa-2b for treating polycythaemia vera without symptomatic splenomegaly

21/04/2020

ID1213: Dupilumab for treating severe asthma

21/04/2020

ID968: Zynteglo for treating transfusion-dependent beta-thalassaemia

21/04/2020

ID1189: Naldemedine for treating opioid-induced constipation

21/04/2020

ID1522: Atezolizumab with nab-paclitaxel for treating PD L1-positive, triple-negative, advanced breast cancer

16/04/2020

ID1511: Ustekinumab for treating moderately to severely active ulcerative colitis

16/04/2020

ID1504: Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer

16/04/2020

ID1299: Larotrectinib for treating advanced solid tumours with TRK fusions